ArticleBlood2021

A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells converted to Tregs to control scurfy syndrome.

Marianne Delville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.